New Zealand markets closed

Enveric Biosciences Inc (SLZA.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.58000.0000 (0.00%)
At close: 08:08PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-51,919
-17,311
-18,504
-48,977
-6,865
-
Depreciation & amortisation
542.035
408.03
435.201
681.612
120.872
-
Deferred income taxes
-
0
-1,504
-7,455
0
-
Stock-based compensation
9,859
2,150
2,621
12,597
1,977
-
Change in working capital
-716.92
-174.75
-217.66
1,185
-369.495
-
Accounts receivable
-
-
-
-
-
1,487
Other working capital
-18,520
-14,100
-17,731
-12,322
-3,933
-
Other non-cash items
-
1,848
-
1,159
1,247
0.001
Net cash provided by operating activities
-17,752
-14,094
-17,147
-11,458
-3,889
-
Cash flows from investing activities
Investments in property, plant and equipment
-767.691
-5.18
-584.165
-864.719
-44.143
-
Acquisitions, net
-
-
-
-
-
-200
Net cash used for investing activities
-767.69
11.667
-584.165
2,191
-44.143
-
Cash flows from financing activities
Debt repayment
-
-
-
0
-191.64
-1,326
Common stock issued
17,222
0
17,222
21,614
488
-
Common stock repurchased
-
-1,052
0
-
-
-
Other financing activities
-
-291.084
958.038
-
3,373
22
Net cash used provided by (used for) financing activities
18,180
-1,343
18,180
24,900
5,531
-
Net change in cash
-247.421
-15,436
367.885
15,778
1,535
-
Cash at beginning of period
21,448
17,724
17,356
1,578
43.714
-
Cash at end of period
21,109
2,288
17,724
17,356
1,578
-
Free cash flow
Operating cash flow
-17,752
-14,094
-17,147
-11,458
-3,889
-
Capital expenditure
-767.691
-5.18
-584.165
-864.719
-44.143
-
Free cash flow
-18,520
-14,100
-17,731
-12,322
-3,933
-